Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study

Kiran Bhave; Sweta Tondare; Prasad Pandit; Rachana Patankar

doi:10.5455/njppp.2022.12.0314520220002042022

2023, Vol: 13, Issue: 3

13/3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2022; 12(11): 1939-1943

doi: 10.5455/njppp.2022.12.0314520220002042022

Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study

Kiran Bhave, Sweta Tondare, Prasad Pandit, Rachana Patankar.

Abstract
Background: Migraine is a debilitating neurological disorder. As a leading cause of disability worldwide, it affects health-related quality of life (HRQoL). There are limited studies assessing the prescription pattern and improvement in HRQoL post-treatment.

Aims and Objectives: This study aims to evaluate the drug use pattern and compare the effects of medications on HRQoL as per Migraine Disability Assessment Score (MIDAS).

Materials and Methods: A prospective observational cross-sectional study was conducted on migraine patients attending neurology OPD at a tertiary care hospital. One hundred and seven patients were recruited by periodic sampling over 6 months. Prescription indicators assessed were number of antimigraine drugs per prescription, frequency of prescribed drugs, prescriptions by generic name, etc. Data were analyzed using descriptive statistics. The HRQoL was assessed after 3 months of medications by telephonic questionnaire. The change was analyzed by Wilcoxon matched pair signed-rank test.

Results: Majority patients were in the third (40.2%) and fourth decade (32.7%) with a female preponderance (72.9%). Nonsteroidal anti-inflammatory drugs were commonly prescribed for aborting acute attacks with naproxen (24.1%) followed by diclofenac (2.71%). Prophylactically topiramate (27.51%), amitriptyline (18.6%), and propranolol (3.1%) were prescribed. About 36.43% of drugs were prescribed by generic names. Improvement in HRQoL was reflected by a significantly reduced MIDAS (13.95 ± 5.20 to 11.39 ± 5.07 [P < 0.05]).

Conclusion: In our study, there was low generic prescribing. Naproxen was most prescribed for acute migraine and topiramate for prophylaxis. The HRQoL significantly improved after 3 months of antimigraine medications causing lesser disease burden.

Key words: Headache; MIDAS; Prescription; HRQoL; Prophylaxis; Generic

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kiran Bhave Articles by Sweta Tondare Articles by Prasad Pandit Articles by Rachana Patankar
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. Natl J Physiol Pharm Pharmacol. 2022; 12(11): 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Web Style

Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. https://www.njppp.com/?mno=4707 [Access: March 02, 2023]. doi:10.5455/njppp.2022.12.0314520220002042022

AMA (American Medical Association) Style

Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. Natl J Physiol Pharm Pharmacol. 2022; 12(11): 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Vancouver/ICMJE Style

Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. Natl J Physiol Pharm Pharmacol. (2022), [cited March 02, 2023]; 12(11): 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Harvard Style

Bhave, K., Tondare, . S., Pandit, . P. & Patankar, . R. (2022) Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. Natl J Physiol Pharm Pharmacol, 12 (11), 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Turabian Style

Bhave, Kiran, Sweta Tondare, Prasad Pandit, and Rachana Patankar. 2022. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (11), 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Chicago Style

Bhave, Kiran, Sweta Tondare, Prasad Pandit, and Rachana Patankar. "Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

MLA (The Modern Language Association) Style

Bhave, Kiran, Sweta Tondare, Prasad Pandit, and Rachana Patankar. "Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study." National Journal of Physiology, Pharmacy and Pharmacology 12.11 (2022), 1939-1943. Print. doi:10.5455/njppp.2022.12.0314520220002042022

APA (American Psychological Association) Style

Bhave, K., Tondare, . S., Pandit, . P. & Patankar, . R. (2022) Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (11), 1939-1943. doi:10.5455/njppp.2022.12.0314520220002042022

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article